教員・教室員について
助教
名前 | 土橋 賢司(つちはし けんじ) |
---|---|
卒業年 | 2008(平成20)年 |
学位取得年月 | 2016年10月 医学博士学位取得 |
専門領域 | 腫瘍内科学、腫瘍生物学 |
資格 | 日本内科学会認定医・総合内科専門医 日本臨床腫瘍学会がん薬物療法専門医・指導医 日本消化器病学会専門医 |
所属学会 | 日本臨床腫瘍学会 日本内科学会 日本癌学会 日本癌治療学会 日本消化器病学会 日本サルコーマ治療研究学会 レックリングハウゼン病学会 米国癌学会 欧州臨床腫瘍学会 |
略歴
2008-2010年 | 聖路加国際病院 初期臨床研修医 |
---|---|
2010-2011年 | 九州大学病院 血液・腫瘍内科 医員 |
2011-2015年9月 | 慶應義塾大学医学部 先端医科学研究所遺伝子制御研究部門(佐谷秀行教授) 研究員 |
2015年10月-2016年3月 | 九州大学病院 血液・腫瘍内科 医員 (外来化学療法室担当) |
2016年4月 | 九州大学病院 遺伝子細胞療法部 医員 |
2017年4月 | 九州大学病院 血液・腫瘍・心血管内科 臨床助教 |
2017年8月 | 同上 助教 |
2022年8月 |
希少がんセンター内科系コーディネーター併任 |
代表的業績
- Yae T, et al. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cells. Nature Communications. 2012;3: 833.
- Tsuchihashi K, et al. Systemic chemotherapy for non-mucinous appendiceal adenocarcinoma: a case report and literature review. International Cancer Conference Journal, 2013;2: 36-40.
- Yoshikawa M, et al. xCT inhibition depletes CD44v-expressing tumor cells that are resistant EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Research, 2013;71:1855-66.
- Seishima R, et al. Ink4a/Arf-dependent Loss of Parietal Cells Induced by Oxidative Stress Promotes CD44-dependent Gastric Tumorigenesis.
Cancer Prevention Research, 2015;8;492-501. - Wang M, et al. CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines. J Control Release. 2016;230:26-33.
- Tsuchihashi K, et al. The EGF receptor promotes the malignant potential of glioma by regulating amino acid Transport system xc(-).
Cancer Research. 2016;76:2954-63 - Tsuchihashi K, et al. Programmed death-ligand 1 expression associates with fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mol Clin Oncol, 2017;6:665-668
- Tsuchihashi K, et al. Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: a case report. Medicine (Baltimore) 2017;96:e8285.
- Tsuchihashi K, et al. Metastatic esophageal cancer presenting as shock by injury of vagus nerve mimicking baroreceptor reflex: A case report. Medicine (Baltimore) 2017;96:e8987.
- Tsuchihashi K, et al. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.Clin Colorectal Cancer 2018;17:e687-e689
- Suina K and Tsuchihashi K (equally contributed), et al. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling. Cancer Sci 2018;109:3874-3882
- Tsuchihashi K, et al. Metastatic esophageal carcinosarcoma comprising neuroendocrine carcinoma, squamous cell carcinoma, and sarcoma: A case report. Medicine (Baltimore) 2018;97: e12796
- Nio K, Tsuchihashi K, et al. Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or Lenvatinib. International Journal of Surgery Oncology. 2020;5:e89.
- Taguchi R, Tsuchihashi K, et al. Thrombocytopenia caused by dexamethasone in a patient with colorectal cancer. Internal Medicine 2020;59:2571-2575.
- Tsuruta N, Tsuchihashi K, et al. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells. Biochem Biophys Res Commun. 2020;530:235-239.
- Tsuchihashi K, et al. Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin. Sci Rep. 2020;10:20896.
- Tsuchihashi K, et al. Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous Polyposis. Case Rep Oncol 2022;15:71–77
- Tsuchihashi K, Hirata Y (equally contributed), et al. Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer. Biochem Biophys Rep. 2022;30:101246.
- Tsuchihashi K, et al. Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan. BMC Cancer.2023;23(1):1046.
- Tsuchihashi K and Baba E.Epithelioid Hemangioendothelioma -Its history, clinical features, molecular biology and current therapy Jpn J Clin Oncol. in press